Health Condition 1: F317- Bipolar disorder, currently in remission
Conditions
Interventions
Intervention1: Oral Acetazolamide upto a maximum of 500mg per day over a period of 8 weeks on patients with Bipolar disorder who are on stable dose of Sodium Valproate.: Oral Acetazolamide upto a maxi
Sponsors
Dr Mathews Joseph Panicker
Eligibility
Inclusion criteria
Inclusion criteria: -Out patients or in patients diagnosed as Bipolar Affective Mood Disorder using MINI PLUS and only on Sodium Valproate. -Both males and females -18 â?? 60 years of age -Without any co-morbid psychiatric illness other than nicotine use.
Exclusion criteria
Exclusion criteria: -Persons on Acetazolamide for any medical reasons. -No known medical conditions in which acetazolamide is contraindicated like hyperchloremic acidosis, hypokalemia, hyponatremia, adrenal insufficiency, impaired kidney function, hypersensitivity to acetazolamide or other sulphonamides, liver diseases. -Pregnancy, lactation -Sub normal intelligence
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of Acetazolamide on weight when combined with Sodium Valproate in patients diagnosed with Bipolar Affective DisorderTimepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Mathews Joseph Panicker
Yenepoya Medical College
Outcome results
None listed